Chemoresistant lung cancer stem cells display high DNA repair capability to remove cisplatin-induced DNA damage

Abstract

Our results further clarify the mechanism of cisplatin resistance in LCSCs in terms of reduced cisplatin uptake and enhanced ability to implement DNA repairs. These findings may aid in the design of the next-generation of platinum-based anticancer drugs.